Why Everyone Knows About Periodontal Disease But Nobody's Fixing It

I've been watching this play out for years, and it still baffles me.

Nearly half of American adults over 30 are dealing with periodontal disease to some degree and causes up to $45 billion in annual productivity loss. The American Heart Association keeps updating their scientific statements about the connection between gum disease and heart health. Every dentist and hygienist knows this disease matters.

And yet we're still losing.

The numbers don't lie. Only 39% of patients reach successful treatment objectives after non-surgical periodontal therapy. Two-thirds walk out of the office with active disease still present.

So what's actually happening here?

Walk into most operatories and you'll hear the same script.

The clinician points at X-rays. They talk about bone loss, gingival margins, and bleeding points. They think they're educating the patient.

They're not.

People don't wake up worried about their gingival margins. They worry about bad breath. They worry about losing teeth. They worry about what's happening to their body.

Here's what actually works: "Mr. Smith, have you noticed an odor, or has anyone in your work or family life mentioned an odor?"

The answer doesn't even matter. What matters is you've connected the clinical problem to something real in the patient's life. Something they can feel. Something that affects their confidence at work or their relationships at home.

Then you can say, "I understand. The best way to treat this issue is by a procedure called scaling and root planing."

People may not know what clinical jargon means. But everyone knows bad breath and wants to take care of it immediately.

The research has been clear for years. People with gum disease have two to three times the risk of having a heart attack, stroke, or other serious cardiovascular event.

That's not a small increase. That's a massive red flag.

So why isn't every practice leading with this?

Because folks are stuck in their ways. Tenured clinicians have been treating patients for decades. They have a routine that works for them, even if it doesn't work for the patient.

It's easier to give patients what they want than to get them to buy into what they need.

But here's the thing: when you skip the cardiac conversation, you're not just missing a sales opportunity. You're missing the chance to save someone's life.

The disease affects overall systemic health. It's common among adults. And while it isn't curable, the right treatment approach will arrest the disease and prevent further damage.

That's the conversation we should be having.

Thanks to growing demand, lithium stock prices grew 2X+ from June 2025 to January 2026. $ALB climbed as high as 227%. $LAC hit 151%. $SQM, 159%.

But the real winner may be a stock not listed on public exchanges, EnergyX.

This $1B unicorn’s patented technology can recover 3X more lithium than traditional methods. That’s earned investment from leaders like General Motors.

Now they’re preparing for commercial production just as experts project 5X demand growth by 2040. They’ve announced what could be one of the US’ largest lithium production facilities and have rights to approximately 150,000 lithium-rich acres across North and South America.

Unlike public stocks, you can buy private EnergyX shares alongside 40,000+ other investors. Invest for $11/share by the 2/26 deadline.

Invest in EnergyX Today

_{This is a paid advertisement for EnergyX Regulation A offering. Please read the offering circular at invest.energyx.com. Under Regulation A, a company may change its share price by up to 20% without requalifying the offering with the Securities and Exchange Commission.}

Let me be clear about something: the protocol exists.

When properly treated, the patient receives scaling and root planing. They come back every three months. The hygienist measures the health of the gums through perio probing and continues treatment to promote gingival reattachment to the hard tissue.

On paper, this works.

In practice, it falls apart.

Why? Because dentists and hygienists aren't doing a good job of linking the disease to systemic and heart health. They're not building value for the patient.

And when you don't build value, patients don't see the point of coming back every three months. They see it as just another cleaning. Just another bill.

The reality is that periodontal pathogens may return to baseline levels within days or months, generally occurring in approximately 9 to 11 weeks.

That three-month maintenance window? It might already be too late for many patients.

But we keep using the same model because it's what we've always done.

Here's what makes this harder than treating tooth decay: you can't see periodontal disease on an X-ray the way you can see a cavity.

Patients look at the image and see nothing wrong. Their teeth look fine to them.

So when you tell them they need thousands of dollars in treatment, their first thought is, "Am I being sold?"

Dentistry is expensive. Clinicians know this. And they get overly sympathetic to patients' budgets.

Since the patient can't see the issue like they can with decayed teeth, the clinician steps off the gas. They don't push. They don't follow up. They let it slide.

The heavy lifting is on the clinician to get buy-in from the patient by linking what's going on in their life with the treatment.

Instead, they get overly clinical. They think patients will get confused. They rely on the fact that the "dentist" said it; therefore, it must be true.

That's not education. That's abdication.

Here's a pattern that shows up in the research that nobody wants to discuss.

Studies show that only 57.8% of general practitioners report instructing patients with assumed compliance on interproximal hygiene, compared to 96.3% of dental hygienists and 93.3% of periodontists.

That's a significant gap.

The same research notes that general dental clinics focus to a greater extent on financially more rewarding restorative treatments than on preventive-oriented care.

In practice, this often means the hygienist drives the perio conversations while others focus elsewhere.

Sometimes the office manager or treatment coordinator tries to help provide urgency and importance. But the pattern in the data is clear.

When restorative treatments generate different returns than preventive care, the outcomes follow predictably.

This isn't about awareness anymore. We're past that.

Every clinician knows periodontal disease matters. Every practice has access to the research about cardiac connections. Every hygienist knows the three-month maintenance protocol.

The problem is execution.

We need to stop speaking in clinical terms and start speaking in patient terms. Bad breath. Heart health. Quality of life.

We need to stop treating this like a one-time procedure and start treating it like the chronic inflammatory disease it is.

We need to fix the incentive structure so dentists have a reason to prioritize disease management over crowns.

And we need to stop blaming patients for non-compliance when we've designed a system that makes compliance nearly impossible.

The gap between what we know and what we do isn't getting smaller on its own.

It's getting wider.

And until we're willing to admit that the problem isn't patient education or awareness, but how we've structured our entire approach to treatment, we'll keep seeing the same mediocre outcomes.

The research is there. The protocols exist. The connection to systemic health is proven.

What's missing is the operational will to actually change how we deliver care.

That's on us.